Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

allogeneic ex-vivo-treated peripheral blood mononuclear cells

A preparation of allogeneic peripheral blood mononuclear cells (PBMCs) treated and induced ex vivo to undergo early apoptosis, with potential immunomodulating and antineoplastic activities. Upon administration of allogeneic ex-vivo-treated PBMCs, the early apoptotic cells are engulfed by macrophages and immature dendritic cells (DCs). This leads to immune modulation, which may result in immune-mediated tumor cell death.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic ex-vivo-treated PBMCs
US brand name:Allocetra-OTS
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search